| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $111.1M | +33.4% |
| Cost of Revenue | $70.6M | -5.8% |
| Gross Profit | $40.5M | +386.6% |
| R&D Expense | $58.1M | -36.3% |
| SG&A Expense | $58.7M | -28.4% |
| Operating Income | -$104.2M | +72.1% |
| Pre-tax Income | -$96.5M | +74.2% |
| Income Tax | $537K | +2.7% |
| Net Income | -$97.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.5M | -10.7% |
| Short-term Investments | $126.5M | -9.1% |
| Accounts Receivable | $17.9M | +23.1% |
| Inventory | $16.4M | -29.3% |
| Current Assets | $219.9M | -16.5% |
| Total Assets | $276.1M | -16.5% |
| Current Liabilities | $78.4M | -4.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.7M | +75.6% |
| Capital Expenditures | $3.8M | +25.0% |
| Investing Cash Flow | $14.7M | -71.0% |
| Financing Cash Flow | $15.4M | -1.7% |
| Free Cash Flow | -$37.5M | +73.4% |
| +74.1% |
| EPS (Basic) | -$2.08 | +79.4% |
| EPS (Diluted) | -$2.08 | +79.4% |
| Long-term Debt |
| $0 |
| -100.0% |
| Total Liabilities | $95.2M | -37.0% |
| Stockholders' Equity | $180.9M | +0.7% |